Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000932799-05-000277
Filing Date
2005-09-07
Accepted
2005-09-07 13:28:58
Documents
2
Period of Report
2005-09-02

Document Format Files

Seq Description Document Type Size
1 horak3_ex.html 3  
1 horak3_ex.xml 3 2229
2 POWER OF ATTORNEY horakpoa.txt EX-24 3378
  Complete submission text file 0000932799-05-000277.txt   7567
Mailing Address C/O DORSEY & WHITNEY LLP 250 PARK AVE NEW YORK NY 10177
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 7329804500
ENZON PHARMACEUTICALS INC (Issuer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O IMMUNOMEDICS INC 300 AMERICAN ROD MORRIS PLAINS NJ 07950
Business Address
HORAK IVAN D (Reporting) CIK: 0001247903 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-12957 | Film No.: 051072352